These include positive estrogen receptor status (ER+), moderate tumor vascularity, absence of extrahepatic disease, good baseline ECOG-PS, and normal baseline liver function tests (transaminases and gamma-glutamyltransferase). The gene discussed is ESR1; the disease is neoplasm.